Amphastar Pharmaceuticals Inc

AMPH

Company Profile

  • Business description

    Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.

  • Contact

    11570 6th Street
    Rancho CucamongaCA91730
    USA

    T: +1 909 980-9484

    https://www.amphastar.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    1,976

Stocks News & Analysis

stocks

ASX property share lifts guidance despite sector headwinds

Aussie property manager lifts earnings expectations despite interest rate uncertainty.
stocks

Investors cheer Guzman dialing back global ambitions

Our view after US restaurants are closed.
stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,945.2066.700.75%
CAC 408,215.2242.110.52%
DAX 4025,216.3431.450.12%
Dow JONES (US)50,748.28286.600.57%
FTSE 10010,497.145.750.05%
HKSE25,328.23271.22-1.06%
NASDAQ26,591.0565.13-0.24%
Nikkei 22564,999.413.320.01%
NZX 50 Index13,227.81158.071.21%
S&P 5007,514.045.08-0.07%
S&P/ASX 2008,717.7065.500.76%
SSE Composite Index4,093.7351.65-1.25%

Market Movers